Skip to main content

Overweight and Its Relation to CHD

UNDERSTANDING CORONARY HEART DISEASE (CHD)

According to current estimates, 64.4 million Americans have one or more types of cardiovascular disease. Within cardiovascular diseases, coronary heart disease (CHD) is the single largest killer of Americans. CHD caused 502,189 deaths in the US in 2001 – about 1 in every 5. The American Heart Association estimates that 13.2 million Americans have CHD. In fact, up to half of all sudden, out-of-hospital cardiac deaths occur in people with no prior diagnosis of heart disease, and over two-thirds of heart attach sufferers have blockages in their arteries considered to be clinically “insignificant” in terms of plaque burden and percent stenosis. Until recently, it was widely held that most heart attacks were caused by a gradual build-up of atherosclerotic plaque within the arteries of the heart (“hardening of the arteries”), impedes blood flow, and eventually results in blocked blood vessels that can cause acute ischemic events such as unstable angina, heart attack, stroke, peripheral vascular disease, and a variety of other related debilitating conditions.


Source: Association for the Eradication of Heart Attack

Scientists now know that life-threatening cardiac events are very often linked to unstable, rupture-prone arterial deposits known as “vulnerable plaques.” These unstable plaques are associated with enlargement of the arterial vessel wall, and consist of soft, biologically active, thrombogenic fatty material covered by a thin fibrous cap and characterized by a large infiltration of activated macrophages, indicating a high level of inflammation. Inflammation leads to an accumulation of proteolytic enzymes, which leads to a breakdown or sudden rupture of the fibrous cap, without warning, resulting in the release or erosion of the fatty lipid core into the blood stream. Exposure to the thromboemboli cascade promotes the formation of blood clots that can cause acute ischemic events, such as unstable angina or myocardial infarction.

Researchers believe that these vulnerable plaques are responsible for 85% or more of all heart attacks, and that the same types of plaque deposits in the carotid and cerebral arteries may account for the majority of ischemic strokes.

Comments

Popular posts from this blog

Monoclonal Antibody Targets, Kills Leukemia Cells

Monoclonal Antibody Targets, Kills Leukemia Cells  Researchers at the University of California, San Diego Moores Cancer Center have identified a humanized monoclonal antibody that targets and directly kills chronic lymphocytic leukemia (CLL) cells The findings, published in the online Early Edition of the Proceedings of the National Academy of Sciences on March 25, 2013 represent a potential new therapy for treating at least some patients with CLL, the most common type of blood cancer in the United States. CLL cells express high levels of a cell-surface glycoprotein receptor called CD44. Principal investigator Thomas Kipps, MD, PhD, Evelyn and Edwin Tasch Chair in Cancer Research, and colleagues identified a monoclonal antibody called RG7356 that specifically targeted CD44 and was directly toxic to cancer cells, but had little effect on normal B cells. Moreover, they found RG7356 induced CLL cells that expressed the protein ZAP-70 to undergo apoptosis or programmed cell dea...

CellSight Contributes Light-Sensitive Retinal Organoids and RPE Cells to New AMD Study

  Department of Ophthalmology Written by  Kara Mason  | December 06, 2023 A partnership between ophthalmology researchers at the  University of Colorado School of Medicine  and Johns Hopkins University expands the understanding of how oxidative stress contributes to the development of choroidal neovascularization (CNV) in patients with age-related macular degeneration (AMD). To study the roles oxidative stress, a condition in which the body lacks antioxidants, and hypoxia play in the progression of AMD, Johns Hopkins University researchers turned to  CellSight , the ocular stem cell and regeneration research program in the  CU Department of Ophthalmology,  for tools that allow researchers to explore specific conditions relevant to AMD. Using human-induced pluripotent stem cells, a type of stem cells that are generated or induced-from cells obtained from an adult person's skin or blood,  CellSight  investigators can recreate human retinal...

Baldness as a Signal of Heart Disease Risk

Baldness as a Signal of Heart Disease Risk Courtesy : NY Times and BMJ online. Baldness may indicate an increased risk for coronary heart disease. The risk is associated only with male pattern baldness, the kind that starts at the top or back of the head, and not with a receding hairline, according to researchers who reviewed six studies that included 37,000 participants. The analysis, published online in BMJ Open , found that baldness increased the risk for heart disease by between 30 and 40 percent compared with men with a full head of hair. They found the association among men 55 to 60 as well as among older men, and the more severe the baldness, the greater the risk. The reason for the association is unclear, but the authors suggest that known risk factors for heart disease — hypertension, high cholesterol, smoking and others — may affect both conditions, and that baldness may be a marker of atherosclerosis. In previous studies, baldness has been linked to an increased risk...